Jayamanne: And we’ve exaggerated the returns, which shows the impact of breaking the chain of compounding. There is value in ...

With most Aussies now holding at least one ETF in their portfolio, it’s a hard proposition to ignore for beginner investors.

David Dreman bought stocks that nobody else wanted. Here are five of his rules for contrarian investing and nine ASX stocks ...

Former Assistant Treasurer Stephen Jones was adamant that this will be a minimal change for the majority. He also confirmed ...

Taken together, Esther thinks that the odds of Redox continuing to grow sales at a double-digit clip look fairly good. Her ...

The announcement sent healthcare stocks plunging in Asia and Europe. Takeda Pharmaceutical TAK dropped 6.5% in Tokyo, while ...

It says government spending on older people, including the age pension, aged care and health care, has increased ...

The United States and China agreed to temporary tariff cuts for the next 90 days while they negotiate a larger trade deal.

Microchip is calling the bottom on the brutal cyclical downturn that weighed its the business for the past several quarters.

Aurizon is at risk of missing the bottom end of the fiscal 2025 EBITDA guidance range of AUD 1.66 billion-AUD 1.74 billion.

Welcome to Stock Showdown, a new feature where we’ll use Morningstar research and insights to compare the business and ...

Australia’s housing supply is falling far short of demand, driving up prices and rents. With approvals down, costs up, and ...